Manuel F. Ugarte‐Gil

2021 DORIS definition of remission in SLE: final recommendations from an international task force

Ronald van Vollenhoven, George Βertsias, Andrea Doria et al. · Lupus Science & Medicine · 2021 · 349 citations · Full text

Medicine, Clinical Sciences, Internal Medicine +8

Associations of baseline use of biologic or targeted synthetic DMARDs with COVID-19 severity in rheumatoid arthritis: Results from the COVID-19 Global Rheumatology Alliance physician registry

Jeffrey A. Sparks, Zachary S. Wallace, Andrea M. Seet et al. · Annals of the Rheumatic Diseases · 2021 · 241 citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +15

Comparison of an interferon-gamma assay with tuberculin skin testing for detection of tuberculosis (TB) infection in patients with rheumatoid arthritis in a TB-endemic population.

Darío Ponce de León, Eduardo M. Acevedo‐Vásquez, Sergio Alvizuri et al. · PubMed · 2008 · 172 citations

Public Health, Immunology, Infectious Diseases +16

Early experience of COVID-19 vaccination in adults with systemic rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance Vaccine Survey

Sebastian E. Sattui, Jean W Liew, Kevin Kennedy et al. · RMD Open · 2021 · 169 citations · Full text

Medicine, Immunology, Internal Medicine +15

First Latin American clinical practice guidelines for the treatment of systemic lupus erythematosus: Latin American Group for the Study of Lupus (GLADEL, Grupo Latino Americano de Estudio del Lupus)–Pan-American League of Associations of Rheumatology (PANLAR)

Bernardo A. Pons‐Estel, Eloísa Bonfá, Enrique R. Soriano et al. · Annals of the Rheumatic Diseases · 2018 · 151 citations · Full text

Life Sciences, Immunology, Internal Medicine +10